Sign In
Buy CRMD
$8.23
+0.0600 (+0.734%)
At Close: Jun 03, 2026
Down 21.2% in 4 Weeks, Here's Why You Should You Buy the Dip in CorMedix (CRMD)
11:36am, Friday, 10'th Sep 2021
CorMedix (CRMD) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against CorMedix Inc. (CRMD)
06:03pm, Thursday, 09'th Sep 2021
LOS ANGELES, Sept. 9, 2021 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming September 20, 2021 deadline to file a lead plaintiff motion in the class action file
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against CorMedix Inc. (CRMD)
08:59pm, Tuesday, 07'th Sep 2021
LOS ANGELES--(BUSINESS WIRE)---- $CRMD #investors--The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against CorMedix Inc. (CRMD)
NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of CorMedix Inc. (NASDAQ: CRMD) between July 8, 2020 and May 13, 2021, inclusive
Los Angeles, California--(Newsfile Corp. - September 7, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against CorMedix Inc.
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against CorMedix Inc. (CRMD)
01:32pm, Tuesday, 07'th Sep 2021
LOS ANGELES--(BUSINESS WIRE)---- $CRMD #CLASSACTION--Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming September 20, 2021 deadline to file a lead plaintiff motion in the class
Why CorMedix Stock Is Getting Crushed Today
11:20am, Tuesday, 07'th Sep 2021
The company announced a delay with resubmitting for FDA approval of its DefenCath antibacterial and antifungal solution.
Why Is CorMedix Stock Dropping On Tuesday?
09:49am, Tuesday, 07'th Sep 2021
CorMedix Inc (NASDAQ: CRMD) stock is plunging after updating its resubmission timeline for the DefenCath marketing application. CorMedix has encountered delays at its third-party contract manufactu
NEW YORK, Sept. 5, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against CorMedix Inc. ("CorMedix" or the "Company") (NASDAQ: CRMD) and certain of its officer
New York, New York--(Newsfile Corp. - September 3, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities o
New York, New York--(Newsfile Corp. - September 1, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of CorMedix Inc. (NASDAQ: CRMD) between July 8,
New York, New York--(Newsfile Corp. - September 1, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities
CLASS ACTION UPDATE for LOTZ, CRMD and SAVA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
05:40am, Monday, 30'th Aug 2021
NEW YORK, NY / ACCESSWIRE / August 30, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholde
SHAREHOLDER ALERT: LOTZ CRMD ATVI: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
11:45am, Sunday, 29'th Aug 2021
NEW YORK, NY / ACCESSWIRE / August 29, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a
SHAREHOLDER ALERT: CRMD ATIP SAVA: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
10:45am, Sunday, 29'th Aug 2021
NEW YORK, NY / ACCESSWIRE / August 29, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a
